Industry Research Reports
Home > Reports > Chemical & Material > Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2025
Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2025
Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 95 Pages
Report ld: 3968416
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Oxaprozin Active Pharmaceutical Ingredients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
By Company
- Granules India Limited
- Huagang Pharm
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Pfizer
- Taj Pharmaceuticals Ltd
- ScinoPharm
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity (99%-99.5%)
- Purity (above 99.5%)
- Purity (below 99 %)
Segment by Application
- Reating Pain
- Fever
- Inflammation
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Oxaprozin Active Pharmaceutical Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaprozin Active Pharmaceutical Ingredients.
The Oxaprozin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxaprozin Active Pharmaceutical Ingredients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaprozin Active Pharmaceutical Ingredients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxaprozin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oxaprozin Active Pharmaceutical Ingredients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oxaprozin Active Pharmaceutical Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Oxaprozin Active Pharmaceutical Ingredients Market Overview
1.1 Product Definition
1.2 Oxaprozin Active Pharmaceutical Ingredients by Type
1.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity (99%-99.5%)
1.2.3 Purity (above 99.5%)
1.2.4 Purity (below 99 %)
1.3 Oxaprozin Active Pharmaceutical Ingredients by Application
1.3.1 Global Oxaprozin Active Pharmaceutical Ingredients Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Reating Pain
1.3.3 Fever
1.3.4 Inflammation
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Estimates and Forecasts (2020-2031)
1.4.4 Global Oxaprozin Active Pharmaceutical Ingredients Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Manufacturers (2020-2025)
2.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Oxaprozin Active Pharmaceutical Ingredients, Industry Ranking, 2023 VS 2024
2.4 Global Oxaprozin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Oxaprozin Active Pharmaceutical Ingredients Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Product Offered and Application
2.8 Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Date of Enter into This Industry
2.9 Oxaprozin Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.9.1 Oxaprozin Active Pharmaceutical Ingredients Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oxaprozin Active Pharmaceutical Ingredients Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oxaprozin Active Pharmaceutical Ingredients Production by Region
3.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Region (2020-2031)
3.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Oxaprozin Active Pharmaceutical Ingredients by Region (2026-2031)
3.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Oxaprozin Active Pharmaceutical Ingredients Production Volume by Region (2020-2031)
3.4.1 Global Oxaprozin Active Pharmaceutical Ingredients Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Oxaprozin Active Pharmaceutical Ingredients by Region (2026-2031)
3.5 Global Oxaprozin Active Pharmaceutical Ingredients Market Price Analysis by Region (2020-2025)
3.6 Global Oxaprozin Active Pharmaceutical Ingredients Production and Value, Year-over-Year Growth
3.6.1 North America Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Oxaprozin Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2020-2031)
4 Oxaprozin Active Pharmaceutical Ingredients Consumption by Region
4.1 Global Oxaprozin Active Pharmaceutical Ingredients Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2020-2031)
4.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2020-2025)
4.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Oxaprozin Active Pharmaceutical Ingredients Production by Type (2020-2031)
5.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Production by Type (2020-2025)
5.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Production by Type (2026-2031)
5.1.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Type (2020-2031)
5.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Type (2020-2031)
5.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Type (2020-2025)
5.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Type (2026-2031)
5.2.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Type (2020-2031)
5.3 Global Oxaprozin Active Pharmaceutical Ingredients Price by Type (2020-2031)
6 Segment by Application
6.1 Global Oxaprozin Active Pharmaceutical Ingredients Production by Application (2020-2031)
6.1.1 Global Oxaprozin Active Pharmaceutical Ingredients Production by Application (2020-2025)
6.1.2 Global Oxaprozin Active Pharmaceutical Ingredients Production by Application (2026-2031)
6.1.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Application (2020-2031)
6.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Application (2020-2031)
6.2.1 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Application (2020-2025)
6.2.2 Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Application (2026-2031)
6.2.3 Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Application (2020-2031)
6.3 Global Oxaprozin Active Pharmaceutical Ingredients Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Granules India Limited
7.1.1 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Company Information
7.1.2 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.1.3 Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Granules India Limited Main Business and Markets Served
7.1.5 Granules India Limited Recent Developments/Updates
7.2 Huagang Pharm
7.2.1 Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Company Information
7.2.2 Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.2.3 Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Huagang Pharm Main Business and Markets Served
7.2.5 Huagang Pharm Recent Developments/Updates
7.3 Hebei Jiheng Pharmaceutical
7.3.1 Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Company Information
7.3.2 Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.3.3 Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hebei Jiheng Pharmaceutical Main Business and Markets Served
7.3.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
7.4 Zhejiang Kangle Pharmaceutical
7.4.1 Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Company Information
7.4.2 Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.4.3 Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Zhejiang Kangle Pharmaceutical Main Business and Markets Served
7.4.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
7.5 Pfizer
7.5.1 Pfizer Oxaprozin Active Pharmaceutical Ingredients Company Information
7.5.2 Pfizer Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.5.3 Pfizer Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Pfizer Main Business and Markets Served
7.5.5 Pfizer Recent Developments/Updates
7.6 Taj Pharmaceuticals Ltd
7.6.1 Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Company Information
7.6.2 Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.6.3 Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Taj Pharmaceuticals Ltd Main Business and Markets Served
7.6.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
7.7 ScinoPharm
7.7.1 ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Company Information
7.7.2 ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Product Portfolio
7.7.3 ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ScinoPharm Main Business and Markets Served
7.7.5 ScinoPharm Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oxaprozin Active Pharmaceutical Ingredients Industry Chain Analysis
8.2 Oxaprozin Active Pharmaceutical Ingredients Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oxaprozin Active Pharmaceutical Ingredients Production Mode & Process Analysis
8.4 Oxaprozin Active Pharmaceutical Ingredients Sales and Marketing
8.4.1 Oxaprozin Active Pharmaceutical Ingredients Sales Channels
8.4.2 Oxaprozin Active Pharmaceutical Ingredients Distributors
8.5 Oxaprozin Active Pharmaceutical Ingredients Customer Analysis
9 Oxaprozin Active Pharmaceutical Ingredients Market Dynamics
9.1 Oxaprozin Active Pharmaceutical Ingredients Industry Trends
9.2 Oxaprozin Active Pharmaceutical Ingredients Market Drivers
9.3 Oxaprozin Active Pharmaceutical Ingredients Market Challenges
9.4 Oxaprozin Active Pharmaceutical Ingredients Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Oxaprozin Active Pharmaceutical Ingredients Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Oxaprozin Active Pharmaceutical Ingredients Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Oxaprozin Active Pharmaceutical Ingredients Production Capacity (Kiloton) by Manufacturers in 2024
Table 4. Global Oxaprozin Active Pharmaceutical Ingredients Production by Manufacturers (2020-2025) & (Kiloton)
Table 5. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Manufacturers (2020-2025)
Table 6. Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Oxaprozin Active Pharmaceutical Ingredients, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Oxaprozin Active Pharmaceutical Ingredients as of 2024)
Table 10. Global Market Oxaprozin Active Pharmaceutical Ingredients Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Product Offered and Application
Table 13. Global Key Manufacturers of Oxaprozin Active Pharmaceutical Ingredients, Date of Enter into This Industry
Table 14. Global Oxaprozin Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Region (2020-2025)
Table 19. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Oxaprozin Active Pharmaceutical Ingredients Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
Table 22. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) by Region (2020-2025)
Table 23. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Region (2020-2025)
Table 24. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) Forecast by Region (2026-2031)
Table 25. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share Forecast by Region (2026-2031)
Table 26. Global Oxaprozin Active Pharmaceutical Ingredients Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Oxaprozin Active Pharmaceutical Ingredients Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
Table 29. Global Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2020-2025) & (Kiloton)
Table 30. Global Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Region (2020-2025)
Table 31. Global Oxaprozin Active Pharmaceutical Ingredients Forecasted Consumption by Region (2026-2031) & (Kiloton)
Table 32. Global Oxaprozin Active Pharmaceutical Ingredients Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
Table 34. North America Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2025) & (Kiloton)
Table 35. North America Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2026-2031) & (Kiloton)
Table 36. Europe Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
Table 37. Europe Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2025) & (Kiloton)
Table 38. Europe Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2026-2031) & (Kiloton)
Table 39. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
Table 40. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2020-2025) & (Kiloton)
Table 41. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption by Region (2026-2031) & (Kiloton)
Table 42. Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
Table 43. Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2020-2025) & (Kiloton)
Table 44. Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption by Country (2026-2031) & (Kiloton)
Table 45. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) by Type (2020-2025)
Table 46. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) by Type (2026-2031)
Table 47. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Type (2020-2025)
Table 48. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Type (2026-2031)
Table 49. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Type (2020-2025)
Table 52. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Type (2026-2031)
Table 53. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2020-2025)
Table 54. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2026-2031)
Table 55. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) by Application (2020-2025)
Table 56. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) by Application (2026-2031)
Table 57. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Application (2020-2025)
Table 58. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Application (2026-2031)
Table 59. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Application (2020-2025)
Table 62. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Application (2026-2031)
Table 63. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2020-2025)
Table 64. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2026-2031)
Table 65. Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 66. Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 67. Granules India Limited Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Granules India Limited Main Business and Markets Served
Table 69. Granules India Limited Recent Developments/Updates
Table 70. Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 71. Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 72. Huagang Pharm Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Huagang Pharm Main Business and Markets Served
Table 74. Huagang Pharm Recent Developments/Updates
Table 75. Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 76. Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 77. Hebei Jiheng Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Hebei Jiheng Pharmaceutical Main Business and Markets Served
Table 79. Hebei Jiheng Pharmaceutical Recent Developments/Updates
Table 80. Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 81. Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 82. Zhejiang Kangle Pharmaceutical Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Zhejiang Kangle Pharmaceutical Main Business and Markets Served
Table 84. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
Table 85. Pfizer Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 86. Pfizer Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 87. Pfizer Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business and Markets Served
Table 89. Pfizer Recent Developments/Updates
Table 90. Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 91. Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 92. Taj Pharmaceuticals Ltd Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Taj Pharmaceuticals Ltd Main Business and Markets Served
Table 94. Taj Pharmaceuticals Ltd Recent Developments/Updates
Table 95. ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Company Information
Table 96. ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Specification and Application
Table 97. ScinoPharm Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. ScinoPharm Main Business and Markets Served
Table 99. ScinoPharm Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Oxaprozin Active Pharmaceutical Ingredients Distributors List
Table 103. Oxaprozin Active Pharmaceutical Ingredients Customers List
Table 104. Oxaprozin Active Pharmaceutical Ingredients Market Trends
Table 105. Oxaprozin Active Pharmaceutical Ingredients Market Drivers
Table 106. Oxaprozin Active Pharmaceutical Ingredients Market Challenges
Table 107. Oxaprozin Active Pharmaceutical Ingredients Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oxaprozin Active Pharmaceutical Ingredients
Figure 2. Global Oxaprozin Active Pharmaceutical Ingredients Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Oxaprozin Active Pharmaceutical Ingredients Market Share by Type: 2024 VS 2031
Figure 4. Purity (99%-99.5%) Product Picture
Figure 5. Purity (above 99.5%) Product Picture
Figure 6. Purity (below 99 %) Product Picture
Figure 7. Global Oxaprozin Active Pharmaceutical Ingredients Market Value by Application, (US$ Million) & (2020-2031)
Figure 8. Global Oxaprozin Active Pharmaceutical Ingredients Market Share by Application: 2024 VS 2031
Figure 9. Reating Pain
Figure 10. Fever
Figure 11. Inflammation
Figure 12. Others
Figure 13. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) & (2020-2031)
Figure 15. Global Oxaprozin Active Pharmaceutical Ingredients Production Capacity (Kiloton) & (2020-2031)
Figure 16. Global Oxaprozin Active Pharmaceutical Ingredients Production (Kiloton) & (2020-2031)
Figure 17. Global Oxaprozin Active Pharmaceutical Ingredients Average Price (US$/Ton) & (2020-2031)
Figure 18. Oxaprozin Active Pharmaceutical Ingredients Report Years Considered
Figure 19. Oxaprozin Active Pharmaceutical Ingredients Production Share by Manufacturers in 2024
Figure 20. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Share by Manufacturers (2024)
Figure 21. Oxaprozin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Oxaprozin Active Pharmaceutical Ingredients Revenue in 2024
Figure 23. Global Oxaprozin Active Pharmaceutical Ingredients Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Oxaprozin Active Pharmaceutical Ingredients Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Oxaprozin Active Pharmaceutical Ingredients Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
Figure 26. Global Oxaprozin Active Pharmaceutical Ingredients Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Oxaprozin Active Pharmaceutical Ingredients Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Oxaprozin Active Pharmaceutical Ingredients Consumption by Region: 2020 VS 2024 VS 2031 (Kiloton)
Figure 32. Global Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 34. North America Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 36. Canada Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 37. Europe Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 38. Europe Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Country (2020-2031)
Figure 39. Germany Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 40. France Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 41. U.K. Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 42. Italy Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 43. Russia Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 44. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 45. Asia Pacific Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Region (2020-2031)
Figure 46. China Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 47. Japan Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 48. South Korea Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 49. China Taiwan Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 50. Southeast Asia Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 51. India Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 52. Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 53. Latin America, Middle East & Africa Oxaprozin Active Pharmaceutical Ingredients Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 55. Brazil Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 56. Turkey Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 57. GCC Countries Oxaprozin Active Pharmaceutical Ingredients Consumption and Growth Rate (2020-2031) & (Kiloton)
Figure 58. Global Production Market Share of Oxaprozin Active Pharmaceutical Ingredients by Type (2020-2031)
Figure 59. Global Production Value Market Share of Oxaprozin Active Pharmaceutical Ingredients by Type (2020-2031)
Figure 60. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Production Market Share of Oxaprozin Active Pharmaceutical Ingredients by Application (2020-2031)
Figure 62. Global Production Value Market Share of Oxaprozin Active Pharmaceutical Ingredients by Application (2020-2031)
Figure 63. Global Oxaprozin Active Pharmaceutical Ingredients Price (US$/Ton) by Application (2020-2031)
Figure 64. Oxaprozin Active Pharmaceutical Ingredients Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Oxaprozin Active Pharmaceutical Ingredients market?
The top companies in the global Oxaprozin Active Pharmaceutical Ingredients market are Granules India Limited、Huagang Pharm、Hebei Jiheng Pharmaceutical.
Related Reports
Oxaprozin Active Pharmaceutical Ingredients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oxaprozin Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 128
USD 3950.00
(Single User License)
Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2026
The global Oxaprozin Active Pharmaceutical Ingredients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Oxaprozin Active Pharmaceutical Ingredients Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oxaprozin Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 149
USD 4900.00
(Single User License)
Oxaprozin Active Pharmaceutical Ingredients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxaprozin Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 109
USD 3950.00
(Single User License)
Global Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2030
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published Date: 2024-04-16
Pages: 93
USD 4900.00
(Single User License)
Oxaprozin Active Pharmaceutical Ingredients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published Date: 2024-02-21
Pages: 91
USD 3950.00
(Single User License)
Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2024
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published Date: 2024-01-08
Pages: 91
USD 2900.00
(Single User License)
Oxaprozin Active Pharmaceutical Ingredients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oxaprozin Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 128
USD 3950.00 (Single User License)Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2026
The global Oxaprozin Active Pharmaceutical Ingredients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)Global Oxaprozin Active Pharmaceutical Ingredients Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oxaprozin Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 149
USD 4900.00 (Single User License)Oxaprozin Active Pharmaceutical Ingredients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oxaprozin Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 109
USD 3950.00 (Single User License)Global Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2030
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published: 2024-04-16
Pages: 93
USD 4900.00 (Single User License)Oxaprozin Active Pharmaceutical Ingredients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published: 2024-02-21
Pages: 91
USD 3950.00 (Single User License)Global Oxaprozin Active Pharmaceutical Ingredients Market Research Report 2024
Oxaprozin, also known as oxaprozinum, is a nonsteroidal anti-inflammatory drug, used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Published: 2024-01-08
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now